Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company’s Tumor Microenvironment Activated ...

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Iovance Biotherapeutics. The Motley Fool has a disclosure policy.

Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, today announced the ...

SOUTH SAN FRANCISCO, Calif. & SEATTLE, May 13, 2025--(BUSINESS WIRE)--Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg ...

SAN CARLOS, Calif. (AP) — SAN CARLOS, Calif. (AP) — Iovance Biotherapeutics Inc. (IOVA) on Thursday reported a loss of $116.2 million in its first quarter. On a per-share basis, the San Carlos ...

Sonoma Biotherapeutics Announces Oral and Poster Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting Sonoma Biotherapeutics, Inc., a clinical-stage ...

Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, will be sharing oral and ...

Prosecutors are moving ahead with charges tied to two Sonoma County teen overdoses, while delaying action in a related case involving two suspected fentanyl deaths. Lea el artículo en español aquí.

After a $23.9 million budget deficit led Sonoma State University to implement campuswide cuts, university officials on Tuesday laid out their recovery plan. The 9-page document, titled "A Bridge ...

(Sonoma, CA) Opened in late 2024, Enclos is set to reshape the fine dining scene in downtown Sonoma, California. Guests are greeted by 100-year-old olive trees, leading to a dining space that ...

This has been a milestone year for Iovance Biotherapeutics. In February, the company received accelerated approval from the Food and Drug Administration (FDA) for lifileucel. The treatment ...